European Summer University
Technologies and Health : Law and Ethics (6-8 July 2009)
Home
Programme
Pratical Infos
Accomodation
Registration

TECHNOLOGIES AND HEALTH : LAW & ETHICS

 

 

MONDAY 6 JULY 2009

 

9:15 - 9:30: Opening - Prof. Yves POULLET (Director of CRID - University of Namur)

 

9:30 - 13:00 : General conference

 

General introduction by Jean Massot (France, Commission Nationale Informatique et Libertés)

Anthony SOLOMONIDES (United Kingdom, University of the west of theEngland): “From Technology to Law and Back Again : Aspects of medical information sharing”

Geneviève SCHAMPS (Belgium, UCL, Centre de droit médical et biomédical)

Herman NYS (Belgium, KULeuven, Centre for Biomedical Ethics and Law)

Yann JOLY (Canada, University of Montreal, Centre de recherche en droit public) : Pharmacogenomic

Marie-Angèle GRIMAUD (Canada, University of Montreal, Centre de recherche en droit public) :l’IIREB

 

 

14:30 - 18:30: Workshop « ICT: friends or enemies of healthcare » (Jean-Marc VAN GYSEGHEM, Belgium, University of Namur, CRID, bar of Brussels)

 

1.         J.-M. VAN GYSEGHEM (Belgium, University of Namur, CRID, bar of Brussels): Introduction

2.         M. ERPICUM (Belgium, SPIRAL, ULg) : "eHealth : trust or distrust between users and health
            professionals?"
 

3.         Dr. Ph. OLIVIER (FRATEM, Belgium): “The setting up of an e-Health network“

4.         Ph. LAURENT (Belgium, University of Namur, CRID) : “IPR and  eHealth

5.         E. GEURTS (Belgium) : “CPVP, Galaxia I.S.E. Germany

 

 

19h30: Diner (on registration)

 

TUESDAY 7 JULY 2009

 

9:00 - 13:00: Workshop « Liabilities and technologies » (Prof. Dr Geneviève SCHAMPS, Belgium, UCL, Centre de droit médical et biomédical, President of the Federal Commission on Patient’s Rights)

 

1.         L. PRUDIL (Czech Republik, Masaryk University, Faculty of Medicine) : “Medical device failure – Moral damage claim. Case study”

2.         A. LOBATO and Claudia CRESPO (Brazil, Federal University of Pelotas) : “Nanotechnologies and liability“

3.         J.-M. MALOTEAUX (Belgium, UCL, Faculty of Medicine, President of the Ethical Committee of the University of Louvain, Membre of the National Consultative Bio-Ethical Committee) : “Risks in new therapies, particularly in the long term

4.         J.-L. FAGNART (Belgium, ULB, Law Faculty; Bar of Brussels) and I. LUTTE (Belgium, Bar of Brussels): “Case-law of risks and liabilities in new treatments“


 

 

14:30 - 18:30: Workshop « Biotechnologies and genetic testing » (Prof. Dr Herman NYS, Belgium, KULeuven, Centre for Biomedical Ethics and Law)

 

1.         H. CARMEN-HOWARD (Canada & Belgium, University of Montreal & KULeuven) (to be confirmed)

2.         Ch. BOUFFARD and R. DROUIN (University of Sheerbroke): “Some thoughts about medical and ethical impacts on antenatal ADN testing on the fœtal cells in the mother’s blood“

3.         A. BENHARKAT (Algeria, Constantine, CHU, Head of the Forensic Medicine Department, Deputy-President of the Mediterranean Society for Forensic Medicine): "In view of the evolution of Biotechnologies, can the physician still act as a defender and a mediator of the patient ? “

4.         A.M. DUGUET (France, University of Paul Sabatier, INSERM) (to be confirmed)

 

 

End of the day

 

WEDNESDAY 8 JULY 2009

 

9:00 - 13:00: Workshop « Sale of drugs on the Internet» (Prof. Dr Stefaan CALLENS, Belgium, KULeuven, Centre for Biomedical Ethics and Law, bar of Brussels)

 

Introduction

1.         S. CALLENS (Belgium, KULeuven, Centre for Biomedical Ethics and Law, bar of Brussels): “Where do we stand? Where do we go?”

 

Public authorities and the sale of drugs on the Internet

2.         E. GEERAERTS (Belgium, Federal Agency for Medicines and Health products)

 

Internet Pharmacies – specific regulations vs. general rules

The case of Poland

3.         N. LOJKO (Poland, Bar of Warsaw, Baker & McKenzie)

The case of Brazil

4.         E. DANTAS (Brazil, Bar of Maceio, Deputy-President of the World Association for Medical Law)

 

Competition law, quality of care and the sale of drugs on the Internet

5.         D. FORNACIARI (KULeuven, Centre for Biomedical Ethics and Law)

 

 

14:30 - 17:30 : Workshop « Pharmacogenomics and Paediatric research» (Yann JOLY, Canada, LLM, Attorney at Law, Project manager, Centre de recherche en droit public, University of Montreal) (Team HumGen International du Centre de recherche en droit public de l’université de Montréal)

Moderator: Marie-Angèle Grimaud, PhD, IIREB Coordinator and Annagrazia Altavilla, Avocate, Espace Ethique Méditerranéen (Marseille)

 

1)         Y. JOLY (Canada, LLM, Lawyer, Project manager, Centre de recherche en droit public): The pharmacogenomy in the XXIst century: perspectives, challenges and issues

2)         M. H ABDUL-RAHMAN (Canada, LLB, Lawyer, Research Agent, Centre de recherche en droit public): The pharmacogenomy and civil liability

3)         H. C. HOWARD (Canada, PhD, Post PhD researcher, Centre for Biomedical Ethics and Law, K.ULeuven): Pharmacogenomy and sale of drugs on the Internet: also for the children ?

4)         W. PINXTEN (KULeuven, Centre for Biomedical Ethics and Law) : “Ethical and legal aspects of paediatric clinical trials

 

End of the day

 

CLOSING TIME